Alex. Brown & Sons

Walgreens Boots Alliance Stockholders Elect Robert L. Huffines to Board of Directors

Retrieved on: 
Thursday, January 25, 2024

Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced the election of Robert L. (Robbie) Huffines to the company’s board of directors at its 2024 Annual Meeting of Stockholders.

Key Points: 
  • Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced the election of Robert L. (Robbie) Huffines to the company’s board of directors at its 2024 Annual Meeting of Stockholders.
  • He joins the board as an independent director and will serve on the board’s Finance and Technology Committee.
  • “I am pleased to welcome Robbie to the WBA Board of Directors,” said Stefano Pessina, executive chairman, Walgreens Boots Alliance.
  • Huffines also currently serves on the boards of directors of Nextech Invest and Eikon Therapeutics.

SAB Biotherapeutics Announces Q3 2023 Financial Results and Provides Company Updates

Retrieved on: 
Tuesday, November 14, 2023

SIOUX FALLS, S.D., Nov. 14, 2023 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that is developing fully-human anti-thymocyte immunoglobulin (hIgG) for delaying the onset or progression of type 1 diabetes (T1D), today reported financial results for the third quarter ended October 31, 2023, and provided a company update.

Key Points: 
  • “The third quarter of 2023 was a pivotal growth point for SAB as we advance SAB-142, our T1D immunotherapy.
  • The full proceeds, when funded, are expected to fund the company through 2026 and through topline Phase 2 results.
  • Russell P. Beyer, former EVP and Chief Financial Officer, departed the Company effective October 27, 2023.
  • The decrease was primarily due to discretionary cost reduction measures and increased efficiencies as we continue to mature as a publicly traded company.

Eikon Therapeutics Announces the Election of Robert L. Huffines to its Board of Directors

Retrieved on: 
Monday, December 4, 2023

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20231204280302/en/
    Eikon Therapeutics announces the election of Robbie Huffines to its Board of Directors.
  • Mr. Huffines is also a member of the board of Nextech Invest Ltd., a cancer-focused venture capital firm headquartered in Zurich, Switzerland.
  • “As recently announced, I am retiring in early 2024 from J.P Morgan and am honored to be joining the Eikon Therapeutics Board.
  • “I find Eikon’s breakthrough enabling technology and world class research talent to be a powerful match with enormous potential.”

SAB Biotherapeutics Appoints Michael G. King Jr. as Chief Financial Officer

Retrieved on: 
Tuesday, October 24, 2023

SIOUX FALLS, S.D., Oct. 24, 2023 (GLOBE NEWSWIRE) -- SAB Biotherapeutics , Inc. (Nasdaq: SABS ), today announced that Michael G. King Jr. has been named Chief Financial Officer.

Key Points: 
  • SIOUX FALLS, S.D., Oct. 24, 2023 (GLOBE NEWSWIRE) -- SAB Biotherapeutics , Inc. (Nasdaq: SABS ), today announced that Michael G. King Jr. has been named Chief Financial Officer.
  • Mr. King received his BA in Finance from the Bernard M. Baruch College of the City University of New York.
  • “Mike has an outstanding track record of best-in-class relationships in the investment community and is a sought-after advisor for companies seeking strong value creation,” said Eddie J. Sullivan, Ph.D., co-founder, President, and Chief Executive Officer of SAB Biotherapeutics.
  • He’s been a wonderful colleague and the Board wishes him great success in his future endeavors.”
    Mr. King said, “It’s an exciting time to work for SAB.

Alex. Brown Realty Rebrands as ABR Capital Partners

Retrieved on: 
Tuesday, January 24, 2023

Brown Realty is now ABR Capital Partners, with a new brand identity, logo, and website.

Key Points: 
  • Brown Realty is now ABR Capital Partners, with a new brand identity, logo, and website.
  • ABR Capital Partners (“ABR”) is a privately-owned real estate investment manager founded in 1972 and headquartered in Baltimore, Maryland.
  • Since its inception, ABR has built a reputation as a trusted, highly focused and value driven middle market real estate investor.
  • Brown & Sons,” said Tom Burton, ABR Senior Managing Director and Chief Investment Officer.

D. Cotton Swindell Elected President of Adams Diversified Equity Fund

Retrieved on: 
Wednesday, January 25, 2023

BALTIMORE, Jan. 25, 2023 (GLOBE NEWSWIRE) -- Adams Diversified Equity Fund, Inc. (NYSE: ADX), one of the nation’s oldest closed-end funds, today announced that D. Cotton Swindell has been elected President of the Fund effective upon CEO and President Mark Stoeckle’s retirement in April.

Key Points: 
  • BALTIMORE, Jan. 25, 2023 (GLOBE NEWSWIRE) -- Adams Diversified Equity Fund, Inc. (NYSE: ADX), one of the nation’s oldest closed-end funds, today announced that D. Cotton Swindell has been elected President of the Fund effective upon CEO and President Mark Stoeckle’s retirement in April.
  • Mr. Swindell has been an Executive Vice President and a portfolio manager of ADX since January 21, 2015.
  • Mr. Swindell has served the Fund in a variety of capacities for the past 20 years.
  • Prior to joining ADX, Mr. Swindell was an Equity analyst with Wachovia Securities and for 10 years, an Equity analyst with Alex.

Alex. Brown Realty Announces John Prugh’s Retirement

Retrieved on: 
Thursday, November 17, 2022

Brown Realty has announced the retirement of John M. Prugh.

Key Points: 
  • Brown Realty has announced the retirement of John M. Prugh.
  • Mr. Prugh was responsible for expanding the firms client base from individual investors to include endowments, foundations, pension plans and other institutional investors.
  • In addition to his role at ABR, Mr. Prugh has held many leadership positions within the Baltimore community.
  • Brown Realty is an independent real estate investment manager specializing in value-add, opportunistic, and core-plus investments in the middle market.

Alex. Brown Realty and Biynah’s Transportation-Related Industrial Portfolio Continues to Grow

Retrieved on: 
Monday, August 29, 2022

Brown Realty (ABR) and Biynah Industrial Partners, LLC (BIP) have recently added four additional assets to its nationwide portfolio of truck terminals and high flow-through industrial assets.

Key Points: 
  • Brown Realty (ABR) and Biynah Industrial Partners, LLC (BIP) have recently added four additional assets to its nationwide portfolio of truck terminals and high flow-through industrial assets.
  • The joint venture is actively pursuing additional opportunities to expand the portfolio, which now includes 14 assets.
  • Brown Realty (ABR) is an independent real estate investment manager specializing in value-add, opportunistic, and core-plus investments in the middle market.
  • www.abrealty.com
    Biynah Industrial Partners, LLC (BIP) is a Minneapolis-based private equity firm that makes direct investments in industrial real estate located throughout the United States.

Alex. Brown Realty and Biynah Industrial Partners Expand Transportation Related Industrial Portfolio

Retrieved on: 
Thursday, June 9, 2022

Brown Realty (ABR) and Biynah Industrial Partners, LLC (BIP) continue to expand their portfolio of truck terminals and high flow-through industrial assets.

Key Points: 
  • Brown Realty (ABR) and Biynah Industrial Partners, LLC (BIP) continue to expand their portfolio of truck terminals and high flow-through industrial assets.
  • We are an active buyer of transportation related industrial properties nationwide, said Jeff Josephs, Managing Partner at BIP.
  • Brown Realty (ABR) is an independent real estate investment manager specializing in value-add, opportunistic, and core-plus investments in the middle market.
  • www.abrealty.com
    Biynah Industrial Partners, LLC (BIP) is a Minneapolis-based private equity firm that makes direct investments in industrial real estate located throughout the United States.

Innovative MedTech Announces Addition of Seasoned Finance Executive to its Advisory Board

Retrieved on: 
Thursday, May 5, 2022

Mr. McDermott said, I am very enthusiastic about the potential of Innovative MedTech and to join its Advisory Board.

Key Points: 
  • Mr. McDermott said, I am very enthusiastic about the potential of Innovative MedTech and to join its Advisory Board.
  • This is a pivotal time in the Companys growth, and I am excited to be a part of the Company and its future.
  • Mr. McDermott was one of the sellers of RX Vitality, Inc., which the Company acquired on or about April 28, 2022.
  • Mr. McDermott spent most of his career at Deutsche Bank and predecessor companies Bankers Trust and Alex, Brown & Sons.